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Abstract
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Two gadolinium(III) chelates, GdNP-DO3A (1-methlyene-(p-NitroPhenol)-1,4,7,10tetraazacycloDOdecane-4,7,10-triAcetate) and GdNP-DO3AM (1-methlyene(pNitroPhenol)-1,4,7,10-tetraazacycloDOdecane-4,7,10-triacetAMide), containing a single
nitrophenolic pendant arm plus either three acetate or three amide pendant arms were synthesized
and characterized. The properties of the gadolinium, terbium, and dysprosium complexes of these
ligands were examined as a function of pH. The extent and mechanism of the changes in water
relaxivity with pH of each gadolinium complex was found to differ substantially for the two
complexes. The water relaxivity of Gd(NP-DO3A) increases from 4.1 mM−1 s−1 at pH 9 to 7.0
mM−1 s−1 at pH 5 as a result of acid-catalyzed dissociation of the nitrophenol from the lanthanide.
The nitrophenol group in Gd(NP-DO3AM) does not dissociate from the metal center even at pH 5;
therefore, the very modest increase in relaxivity in this complex must be ascribed to an increase in
prototropic exchange rate of the bound water and/or phenolic protons.

Introduction
The use of paramagnetic metal complexes as contrast media in magnetic resonance imaging
(MRI) is now widely accepted in diagnostic radiology.1–3 Agents currently approved for
clinical use are based upon low-molecular weight chelates of gadolinium that partition
throughout all extra cellular space and catalyze the relaxation of nearby water protons. Areas
of regionally high contrast agent concentration are delineated by enhanced positive contrast in
T1-weighted MR images. The relaxivity, the increase in the rate of water proton relaxation rate
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per unit contrast agent, of all current clinical agents is ~4 mM−1 s−1. Much new developmental
effort has focused on methods of improving relaxivity as a means of enhancing overall
sensitivity of these nonspecific perfusion agents. Nonetheless, this family of agents has proven
to be quite valuable even with a modest relaxivity.1,2 New paradigms for MR contrast agents
will undoubtedly extend their utility to measures of pH changes or thermal variations. An
elegant example of a potential next-generation functional imaging agent was described by
Meade et al.4 In that work, a Gd(DO3A) derivative possessing a covalently linked β-galactose
moiety was prepared in such a way as to block external coordination of water to the central
gadolinium ion. Subsequent exposure to β-galactosidase cleaves the saccharide from the
complex, opening up a vacant coordination site to allow water direct access to the gadolinium
center. Exchange of coordinated water molecules with the bulk solvent is a primary mechanism
by which these chelates catalyze water proton relaxation so that modulating the number of
water molecules coordinated in the inner sphere will modulate the relaxivity, in this case in
response to the presence of β-galactosidase.

NIH-PA Author Manuscript

Modulation of the hydration state, q, has been used to create agents that change relaxivity in
response to pH and calcium and zinc ion concentrations.5–8 Lowe et al. employed a
toluenesulfonamide as a pH labile ligating group in a Gd(DO3A) chelate;5 as the pH of a
solution is reduced, the sulfonamide becomes protonated and dissociates from the metal center.
This increases the hydration state from q = 1 to q = 2, and a corresponding increase in relaxivity
is observed. These authors also reported that careful consideration must be given to the ligating
ability and pKa of the pH labile ligand to observe this effect.5,9 We have recently observed a
similar pH-sensitive dissociation in complexes with one p-nitrophenolic ligating group. The
results of studies performed on the lanthanide(III) complexes of two ligands, the triacetate (NPDO3A) and triamide (NP-DO3AM) (Chart 1) are reported herein. These studies highlight the
extent to which the choice of other ligating groups in the complex can affect the success of this
type of responsive agent.

Results and Discussion
Synthesis
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The ligand NP-DO3A was synthesized according to the route shown in Scheme 1. 2Hydroxy-5-nitrobenzyl bromide was added to 2 equiv of cyclen in dioxane. Mono-alkylated
cyclen was separated from di-substituted cyclens by column chromatography and residual
cyclen removed by trituration of the mono-alkylated from chloroform. The acetates were then
introduced into the mono-alkylated cyclen 1 using bromoacetic acid in water at pH 8.5. After
precipitation from acidified water, NP-DO3A was obtained in an overall yield of 27%. The
lanthanide complexes of NP-DO3A were synthesized from the corresponding lanthanide
chloride in water at pH 4.5.
Considering the low overall yield obtained in the synthesis of NP-DO3A, a different approach
was taken in the synthesis of the triamide derivative, NP-DO3AM (Scheme 2). Here, three
cyclen amines were first protected as tert-butoxycarbamates using di-tert-butyl dicarbonate.
10 The remaining amine was then orthogonally protected as a benzyloxycarbamate using benzyl
chloroformate. The mono-Cbz-protected cyclen 4 was obtained by removal of the Boc groups
using methanolic hydrochloric acid. After liberation of the free base by base extraction, the
three amines of 4 were alkylated with bromoacetamide, using standard conditions (K2CO3/
MeCN). DO3AM was obtained from the Cbz-protected DO3AM 5 by hydrogenolysis of the
benzyloxycarbamate with H2 and 10% palladium on carbon. 2-Hydroxy-5-nitrobenzyl
bromide was then used to alkylate the fourth nitrogen of DO3AM in ethanol, using K2CO3 as
a base. After crystallization from methanol and acetonitrile the ligand NP-DO3AM was
obtained in an overall yield of 48%. The lanthanide complexes of NP-DO3AM were prepared
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from equimolar quantities of the ligand NP-DO3AM and either the lanthanide chloride or
triflate at 60 °C in water.
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Crystal Structure
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An X-ray-quality crystal of the europium(III) salt of NP-DO3AM (Eu(NP-DO3AM)) was
grown from aqueous solution (pH 5) by slow evaporation at room temperature (see structure
determination data in Table 1). The structure obtained by X-ray diffraction is shown in Figure
1. The complex crystallizes in the P1̄ space group with two complexes, replete with coordinated
water molecules, and four triflate counterions per unit cell. Since there are only two counterions
per complex present in the unit cell, the overall formal charge of the complex is 2+. This
indicates that the phenol is deprotonated in this structure. The arrangement of donor atoms
around the europium cation resembles that observed in crystal structures of other complexes
of this type. The macrocycle adopts a [3333] conformation with each ethylene bridge adopting
a gauche conformation (average N–C–C–N torsion angle, 60.6°). The four nitrogen atoms of
the macrocycle adopt a coplanar arrangement on one face of the europium ion. The four oxygen
atoms of the pendant arms adopt a similar coplanar arrangement, sandwiching the europium
ion. A water molecule caps the complex sitting above the plane of the oxygen atoms. The
torsion angle between the N4 and O4 planes of 37° defines the coordination geometry as a
distorted monocapped square antiprism. Examination of the data (Table 2) reveals that a degree
of distortion is present in the structure presumably the result of incorporation of the sixmembered chelate of the phenol. The europium–nitrogen, –amide oxygen and –water oxygen
bond lengths are comparable with those reported for other tetraamide derivatives of DOTA.
11,12 The Eu–O
phen bond distance is substantially shorter (0.15 Å) than the three Eu–Oamide
bonds, presumably reflecting the ionic nature of the phenoxide oxygen atom. The two triflate
anions lie above the coordinated water molecule (Figure 1) with each triflate positioned such
that a hydrogen bond from one triflate oxygen to one of the protons of coordinated water
molecule is possible. The distances between the triflate oxygen and the water oxygen are 2.988
and 2.910 Å, respectively, consistent with hydrogen-bonding interactions. These conclusions
are supported by the observations of Parker and co-workers who observed similar hydrogen
bonding interactions with triflate anions in related tetraamide complexes.12
Relaxivity Measurements
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The effect of pH upon the relaxivity of the two corresponding gadolinium complexes was
examined at 25 °C and 20 MHz (Figure 2). The pH profile of Gd(NP-DO3A) shows a fairly
substantial relaxivity enhancement (71%) on passing from high to low pH. This relaxivity
enhancement was found to be reversible, and measurements repeated after incubation for 2
days confirmed that the enhancement was not the result of dissociation of the gadolinium ion.
The relaxivity pH profile is noticeably different from that observed for Gd(DOTA)− which
remains flat across this same pH range.13 The form of the change is also radically different
from that of Gd(DO3A) wherein the pH profile remains flat until below pH 4 then, rises
dramatically at lower pH values.13 Rather, the relaxivity enhancement observed for Gd(NPDO3A) is consistent with a q = 1, anionic complex at high pH that becomes a q = 2, neutral
complex at low pH as the phenol becomes protonated and dissociates. The relaxivity observed
at high pH (r1 = 4.1 mM−1 s−1) is comparable with that of Gd(DOTA)− (r1 = 4.2 mM−1 s−1)
14 and at low pH (r = 7.0 mM−1 s−1) with that measured for Gd(DO3A) (r = 6.9 mM−1
1
1
s−1).
An enhancement in the relaxivity of Gd(NP-DO3AM) was also observed at lower pH values,
but in this case the enhancement was more modest, ~25%. The much smaller relaxivity
enhancement observed for Gd(NP-DO3AM) is more difficult to understand in terms of phenol
dissociation. The relaxivity value at high pH (r1 = 2.8 mM−1 s−1) falls within the range expected
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for a dicationic, q = 1 complex.11 The relaxivity at low pH (r1 = 3.4 mM−1 s−1), however, falls
short of that observed for the q = 2 Gd(DO3AM)3+ (r1 = 4.7 mM−1 s−1, pH 4 and 9).
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The relaxivity pH profiles in Figure 2 were fitted to a simple protonation equilibrium (eq 1).
The pKa value of Gd(NP-DO3A) was determined by potentiometric titration at 7.36 (±0.04),
and a good fit for the data was obtained using this value. In contrast the pKa value determined
by potentiometric titration for Yb(NP-DO3AM) was significantly lower 7.22 (±0.05).
However, this value does not readily allow the relaxivity data to be fitted, in fact an apparent
pKa value of 6.48 is obtained for Gd(NP-DO3AM) when the relaxivity data are fitted to eq 1.
(1)
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That the pKa values of Ln(NP-DO3AM) complexes are lower than those of the corresponding
acetate analogues may easily be rationalized in terms of the electron-donating ability of the
other pendant arms in the complex. Acetates are ionic electron donors and therefore much more
effective electron donors than the nonionic amides. Given the increased electron donation to
the central lanthanide in Ln(NP-DO3A) complexes, it is expected that the lanthanide will be
less electron deficient in these complexes than in the corresponding Ln(NP-DO3AM)
complexes. Ln(NP-DO3A) complexes will therefore have less demand for electron density
from the phenolic group, raising the pKa of the phenolic proton This, in part, accounts for the
higher pH range over which the relaxivity is enhanced for Gd(NP-DO3A). However, it is
apparent that a difference in the mechanism by which these two complexes enhance relaxivity
exists. The relaxivity enhancement of Gd(NP-DO3A) occurs as the phenolic group is being
protonated, whereas the enhancement observed for Gd(NP-DO3AM) occurs at below the pH
at which the phenol is protonated. We postulate that the origin of this difference in mechanism
is also the result of differences in the electron-donating ability of the other ligating groups
present in these two complexes.
Luminescence and NMR Measurements
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Lanthanide-based luminescence is an invaluable tool for probing the structure and behavior of
lanthanide complexes, giving information on the extent of hydration, interactions with cations
and anions, as well as structural and electronic aspects of a complex. Luminescence is
especially useful for measuring the hydration state, q, of lanthanide complexes using Horrocks’
method15,16 or a modified method reported by Parker and co-workers.17 The intensity of
lanthanide-based luminescent emission may often be enhanced by excitation of the lanthanide
ion via a sensitizing chromophore. However, the p-nitrophenol substituent proves to be a
hindrance rather than a help in this regard. Europium and terbium are the most commonly
studied lanthanide ions due to their long-lived excited states. But, due to the comparative ease
with which the Eu3+ ion may be reduced (Eox ≈ 0.8 V) the study of europium by luminescence
in this case was not feasible. Cyclic voltammograms of Gd(NP-DO3AM) over the pH range
4.1–7.6 show that the first oxidation of the p-nitrophenol moiety occurs at 128 mV (referenced
to Ag/AgCl) and is insensitive to pH. Thus ligand–metal charge transfer (LMCT) from the
readily oxidized p-nitrophenol group rapidly quenches the excited state of the Eu3+ ion.
Europium-based emission in these ligands is so weak that a study of these complexes was
precluded. This limited study to the Tb3+ complexes.
Nonradiative deactivation of the excited state of terbium by proximate OH oscillators causes
some quenching of luminescent emission. The more OH oscillators present the greater the
extent of this quenching effect, and so lanthanides with more coordinated water molecules will
have shorter luminescent lifetimes. The lifetime of terbium-based emission measured for Tb
(NP-DO3A) (λex = 270 nm, λem = 545 nm) at high pH was around twice as long as that measured
J Am Chem Soc. Author manuscript; available in PMC 2009 September 10.
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at low pH (Figure 3). This observation is consistent with a change in the number of proximate
OH oscillators with changing pH. However, an increase in the number of proximate OH
oscillators is not the only mechanism by which a change in emission intensity may be observed
as a function of changing pH. If the energy gap between the triplet energy level of an adjacent
aromatic chromophore and the terbium excited state (5D4) is very small, then energy may not
only pass from the chromophore to terbium ion but also back again. This back energy transfer
(BET) will result in an increase in ligand-based emission at the expense of terbium-based
emission. The lifetimes recorded for Tb(NP-DO3A) at both low and high pH (τTb = 0.25–0.58
ms) are considerably shorter than those observed for other terbium complexes (typical lifetimes
are τTb ≈ 1.0 ms for q = 3 complexes and ~3.0 ms for q = 0 complexes).17 Such short luminescent
lifetimes suggest that another nonradiative decay mechanism takes place in this system besides
the vibronic quenching of OH oscillators. To investigate this further, the triplet energy level
of Gd(NP-DO3A) was measured at 77 K. At pH 4.0 the T1 energy level lies some 2000
cm−1 above the 5D4 state of Tb and 1800 cm−1 higher at pH 8.3 (Figure 4). An energy gap of
this size is small enough to allow a considerable amount of BET, hence, the shorter than
expected luminescent lifetimes.18 However, since no substantial change in the triplet energy
level is observed with pH and the change in lifetime mirrors the relaxivity profile of Gd(NPDO3A), it seems likely that a change in the number of OH oscillators is related to the relaxation
switching effect. This is further supported by the observation that the pH range over which
terbium emission decreases is identical to that over which the relaxivity is enhanced.
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In contrast to the observation for Tb(NP-DO3A), when the terbium-based luminescence of Tb
(NP-DO3AM) was measured as a function of pH, the intensity of emission was found to drop
rapidly with rising pH until at pH 7 almost no emission intensity could be detected. This trend
is the reverse of that observed for Tb(NP-DO3A); it is also a much more dramatic change and
one which cannot be explained by changes in the hydration state of Tb3+. Measurement of the
triplet energy level of Gd(NP-DO3AM) at 77 K indicates a smaller energy gap, 1700 cm−1 at
pH 4.1. However, this energy gap closes as the pH rises until at pH 7.0 the gap is just 500
cm−1 (Figure 4). Such a small gap increases the extent of BET thereby, quenching nearly all
of the terbium-based luminescent intensity. Since the luminescent lifetime of Tb(NP-DO3AM)
at high pH is so short, accurate measurement is not feasible. Thus, measuring the hydration
state of the complexes by Horrocks’ method is not viable.

NIH-PA Author Manuscript

In light of the BET inherent in the luminescent behavior of the terbium complexes a second
method of determining the hydration state was employed. The contact shift arising from
exchange of water molecules coordinated to Dy3+ gives rise to a shift in the bulk water
resonance in the 17O NMR spectrum. The hydration state may be determined by monitoring
the dysprosium-induced shift of the bulk water resonance as a function of the concentration of
the dysprosium complex.19 The hydration states of Dy(NP-DO3A) and Dy(NP-DO3AM) were
determined under both basic and acidic conditions (Supporting information). As anticipated,
the hydration state of Dy(NP-DO3A) at pD 4 was determined to be 1.8, whereas at pD 9 the
value of q was 0.92. In contrast, the hydration state of Dy(NP-DO3AM) does not vary
significantly between the two pHs, with values of q = 1.1 and 1.2 being determined at pD 4
and 9, respectively. These results help us understand the origin of the relaxivity enhancement
in each complex.
In the case of Gd(NP-DO3A) an increase in proton concentration results in protonation of the
phenoxide oxygen with subsequent dissociation of the phenolic pendant arm from the metal
center. This vacates a coordination site, thereby allowing coordination of a second water
molecule and an increase in relaxivity. Thus, the relaxivity enhancement closely correlates
with the pKa of the phenol. The origin of the relaxivity enhancement observed for Gd(NPDO3AM) is more difficult to pin down, but the dissociation of the nitrophenol pendant arm
from the metal center can be ruled out. Of course, exchange of coordinated water molecules
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with the bulk solvent is not the only means by which inner sphere relaxivity may be effected.
It is sufficient that only protons in the inner sphere exchange with the bulk; thus, a change in
the number of exchangeable protons on the complex, or in the rate that they exchange, would
be sufficient to effect a change in relaxivity. More slowly exchanging systems may be probed
by the use of saturation transfer NMR experiments. In an attempt to identify any site that may
be in slow exchange, saturation transfer experiments were performed in H2O, at 0 °C
presaturating at increments across the frequency range from +60 to −60 ppm. The effect of
presaturation upon the intensity of the bulk water signal was monitored, any decrease in bulk
water intensity being indicative of a two-pool exchange process. At both low and high pH (4
and 9) no saturation transfer effects were observed, suggesting that a change from a slowexchange regime was not involved in the relaxivity enhancement mechanism.
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The fact that the relaxivity enhancement of Gd(NP-DO3AM) does not directly correspond to
a pKa in the complex may, however, hold a clue to the origin of the relaxivity change. By
plotting the relaxivity profile of Gd(NP-DO3AM) alongside the data from the potentiometric
titration (Figure 5) it can be seen that the pKa of 7.22 (±0.05) determined from the
potentiometric titration lies close to the onset of the relaxivity enhancement. We can imagine
that around its pKa value the oxygen of the phenol, which remains coordinated to the metal
center, is transiently protonated; that is to say that, although the phenol is protonated, the
protons are in extremely rapid exchange with the bulk solvent and do not reside on the complex
long enough to be efficiently relaxed. As the pH is lowered further, the rate of this exchange
slows down to such an extent that the protons reside on the complex long enough for relaxation
by gadolinium to occur before they are replaced. In this way the protonated phenol pendant
arm begins to contribute to the overall relaxivity of the complex through prototopic exchange
but only at pH values below the pKa of the phenol. Once the rate of prototopic exchange in the
complex plateaus, so does the relaxivity enhancement. The similarity of this pKa value (7.22)
with that of the phenol in Gd(NP-DO3A) (7.36) leads us to conclude that the observed pKa is
that of the phenol. Deprotonation of the phenol improves the electron-donating capacity of the
phenol in this complex which in turn appears to substantially raise the pKa of the coordinated
water molecule. The pKa of the coordinated water molecule in Yb(NP-DO3AM) was
determined to be 10.20 (±0.04), substantially higher than the value of 7.90 determined for
tricationic tetraamide complexes by Parker and co-workers.11 In this respect it is expected that
prototopic exchange of the water protons are not significantly involved in the mechanism of
relaxivity enhancement for this complex. The differences in the magnitude and pH of the
relaxivity enhancements observed for these two complexes can readily be accounted for by the
radical change in mechanism observed when the nature of other ligating groups in the chelate
are altered.
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Effect of Endogenous Anions and Complex Stability
The decidedly small relaxivity enhancement observed for Gd(NP-DO3AM) means that this
complex has less viability as a contrast agent for MR imaging. The more substantial increase
observed for Gd(NP-DO3A) on the other hand could render this a useful basis for the design
of a practical responsive MR imaging agent. However, one feature of lanthanide complexes in
which two coordination sites of the metal ion are available for water molecules is that they can
bind endogenous anions, displacing the inner sphere water molecules.18,20–23 Clearly such
binding is undesirable since it results in a lowering of relaxivity and perturbation of the
inflection point. To assess the effect of endogenous anions upon the relaxivity, 1 mM solutions
of Gd(NP-DO3A) were titrated against citrate, acetate, lactate, and phosphate at both pH 4 and
9. In the presence of up to 40 equiv of each anion, no effect upon relaxation rate was observed,
suggesting that none of these endogenous anions bind to the complex in either the q = 1 or q
= 2 hydration states (Supporting Information). Although not measured here, the effect of
carbonate binding has also been reported to have deleterious effects upon relaxivity.5,18
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However, the effects of carbonate are unlikely to represent a serious drawback to the use of
Gd(NP-DO3A) in vivo since the carbonates are only observed to bind in a bidentate manner.
Thus, carbonate is only likely to affect the complex at lower pH when the phenolic pendant
arm has dissociated; however, the amount of bicarbonate in solution diminishes as the pH is
lowered. Recently, Parker and co-workers described an elegant solution to bicarbonate binding
that could easily be incorporated into this chelate.24 The onset of carbonate binding was found
to be prevented by incorporating anionic substituents into the chelate to leave it formally
negatively charged.
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One further consideration as to whether a complex may be used in vivo is the stability of the
complex. In this regard good kinetic stability is a more important feature of a complex than
thermodynamic stability. This is because ultimately it is only important that the rate of complex
dissociation is slow enough that the complex is excreted from the body before dissociation
occurs. Octadentate ligands such as DOTA and HP-DO3A form extremely kinetically and
thermodynamically stable complexes with gadolinium, and it is reasonable to assume that in
octadentate form, NP-DO3A will also form highly stable complexes. However, under acidic
conditions NP-DO3A becomes a heptadentate ligand, and such ligands are generally known
to be less kinetically inert than their octadentate counterparts. Since the demetalation of these
complexes is believed to be a cation-mediated process, usually via protons or Zn2+ ions, the
kinetic stability of the complex was assessed by examining the extent of dissociation induced
by the presence of these two cations. Accordingly, a solution of 177Lu(NP-DO3A) was
synthesized using a 5-fold excess of ligand. After verification that better than 98% of the
lanthanide ion had been complexed, aliquots of the solution were taken and adjusted to different
pH values over the range 1–11. After incubation, the amount of 177Lu liberated from the
complex after 5 min, 2 h, 6 h, and 24 h was determined at each pH point by eluting a sample
through a Sephadex G-50 column. The radioactivities of the eluent and the column were then
compared. The intact complex elutes, but free lutetium is retained by the column, so that by
comparing the radioactivity of the two the percentage of free lutetium present may be
determined. The results (Figure 6) show unequivocally that lanthanide complexes of NP-DO3A
are kinetically inert over a pH range from 4 to 11. At lower pH values (pH 1–3) dissociation
of the lutetium ion is observed. The extent of dissociation does not alter significantly as a
function of time, suggesting that the equilibrium position is achieved rapidly. A similar
technique was used to assess the effect of Zn2+ upon the kinetic stability of the complex. A 1
mM solution of 177LuNP-DO3A was prepared using a 3-fold excess of the ligand. The pH was
adjusted to 7.4 and ZnCl2 added such that the solution was 3 mM in zinc. The solution was
incubated for 24 h, and aliquots were removed after 5 min, 2 h, 16 h, and 24 h. The extent of
complex dissociation measured using the method described above. Over the course of the
experiment the extent of demetalation by Zn2+ was found to be less than 2%. The stability over
such a wide pH range and in response to Zn2+ ions suggests that the lanthanide complexes of
NP-DO3A should exhibit favorable in vivo stabilities.

Conclusions
We have successfully demonstrated that a methylene nitro-phenol pendant arm may be
employed as a pH-responsive pendant arm in DO3A-type complexes. The pH range over which
this pendant arm dissociates from the central lanthanide ion renders it ideal as the basis of new
pH-responsive contrast media for MRI. In addition, the relaxivity profile of Gd(NP-DO3A)
appears to be unaffected by endogenous anions, and the complex is found to be inert to
demetalation over the pH range 2–11 and in response to Zn2+ ions. Substitution of amide
pendant arms for acetates has several deleterious effects on the complex. The reduced electrondonating capacity of the amide-ligating groups renders the central lanthanide ion too electron
deficient to release the nitrophenol. In consequence, the relaxivity enhancement of [Gd(NP-
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DO3AM)] is rather modest and appears to arise from prototopic exchange of the phenolic
proton as it becomes protonated at lower pH.
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Experimental Section
General Remarks

NIH-PA Author Manuscript

All solvents and reagents were purchased from commercial sources and used as received. 1H
and 13C NMR spectra were recorded on a JEOL Eclipse 270 spectrometer at 270.17 and 67.93
MHz, respectively, or on a Bruker Avance spectrometer at 250.13 and 62.89 MHz,
respectively. 17O NMR spectra were recorded on a Varian Inova 500 spectrometer operating
67.72 MHz. Relaxation measurements were made using an MRS-6 NMR Analyzer from the
Institut “Jožef Stefan”, Ljubljana, Slovenjia, operating at 20 MHz. Luminescence spectra were
recorded on a Perkin-Elmer LS55 or an Edinburgh Instruments nF 900 fluorimeter. The pH of
luminescence samples were measured using a Fisher Accumet 925 pH meter equipped with an
Orion 8103 Ross combination pH electrode. The pH of luminescence samples was altered by
addition of solid lithium hydroxide monohydrate or p-toluenesulfonic acid. Triplet energy
levels were determined from the measured emission spectra of frozen samples of the
corresponding gadolinium(III) complex at 77 K. Singlet energy levels were obtained by
comparing the excitation spectra and the absorption spectra of the complexes recorded on a
Hewlett-Packard 8453 UV–visible spectrometer. Cyclic voltammograms were recorded on a
BAS CV-50W voltammetric analyzer using a glassy carbon working electrode, platinum wire
auxiliary electrode, and Ag/AgCl reference electrode. Samples were prepared at 0.6 mM
concentrations using a 50 mM solution of tetrabutylammonium perchlorate in acetonitrile and
a buffer solution of either phosphate-citrate or tris buffer.
1-Methlyene-(p-nitrophenol)-1,4,7,10-tetraazacyclododecane (1)

NIH-PA Author Manuscript

To a stirred dioxane solution (20 mL) of 1,4,7,10-tetraazacyclododecane (2.3 g, 14.0 mmol)
was added a solution of 2-hydroxy-5-nitrobenzyl bromide (1.2 g, 7.0 mmol) in dioxane (15
mL). After 5 min, K2CO3 (1 g, 7.2 mmol) was added and the reaction stirred for 1 h at ambient
temperature. The reaction mixture was then filtered and the filtrate concentrated in vacuo to
give a yellow semisolid which was purified by column chromatography over silica gel eluting
with CHCl3/MeOH/NH4OH (3:2:1). The title compound was isolated from the slower-moving
yellow fraction which also contained cyclen starting material. The resulting yellow oil was
triturated with CHCl3 (100 mL) to remove cyclen and filtered to afford the title compound as
a crystalline yellow solid (1.2 g, 55%): mp 142–145 °C. 1H NMR (250 MHz, D2O): δ = 7.84
(2H, m, 4-Ph,6-Ph), 6.30 (1H m, 3-Ph), 3.39 (2H, s, NCH2Ar), 2.70–2.87 (16H, m br, ring
CH2). 13C NMR (62.9 MHz, D2O): δ = 45.3 (ring CH2), 45.5 (ring CH2), 47.2 (ring CH2), 51.7
(ring CH2), 56.3 (NCH2Ar), 122.0 (4-Ph), 128.3 (5-Ph), 130.9 (6-Ph), 131.9 (1-Ph), 135.6 (3Ph), 180.1 (2-Ph). νmax/cm−1: 3356 br (NH/OH), 2994, 2957, 2849, 1588, 1472, 1460, 1434,
1273, 1241, 1168, 1132, 1086. HRMS (MALDI): C15H26N5O3 ([MH]+) requires 324.2037,
found 324.2033.
1-Methlyene-(p-nitrophenol)-1,4,7,10-tetrazacyclododecane-4,7,10-triacetic Acid (NP-DO3A)
The mono-alkylated cyclen (1) (0.2 g, 0.6 mmol) was dissolved in water (5 mL) and the pH
adjusted to 5 using HCl (12 N). A solution of bromoacetic acid (309 mg, 2.2 mmol) in water
(10 mL) was added in one portion and the pH adjusted to and maintained at 8.5 by addition of
45% KOH solution. Once the pH was stabilized at 8.5 for 1 h, the pH was raised to 11 and
maintained for 6 h. The solution was then cooled in an ice bath and acidified to pH 2 with
concentrated HCl. A saturated solution of KCl was then added to facilitate crystallization of
the desired product. After stirring for 1 h the colorless precipitate was filtered and dried in
vacuo to afford the title compound as a colorless solid (150 mg, 49%): mp 230–235 °C
dec. 1H NMR (250 MHz, D2O): δ = 7.87 (2H, m, Ph-4, Ph-6), 6.38 (1H, m, Ph-3), 3.39 (2H,
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s, NCH2Ar), 3.01-2.90 (16H, m br, ring CH2), 2.74 (2H, s, NCH2CO2), 2.67 (4H, s,
NCH2CO2). 13C NMR (62.9 MHz, D2O): δ = 51.3 (ring CH2), 55.0 (ring CH2), 55.4 (ring
CH2), 58.3 (NCH2CO2), 60.6 (NCH2CO2), 62.1 (NCH2Ar), 121.2 (4-Ph), 128.4 (5-Ph), 130.6
(6-Ph), 132.9 (1-Ph), 137.5 (3-Ph), 175.5 (2-Ph), 182.1 (C═O), 183.4 (C═O). νmax/cm−1: 3378
br (OH), 3075, 2961, 2861, 1717 (C═O), 1595, 1526, 1456, 1395, 1341, 1288, 1234, 1094.
HRMS (MALDI) C21H32N5O9 ([MH]+) requires 498.2202, found 498.2180.
1,4,7-Tris-tert-butoxycarbonyl-1,4,7,10-tetraazacyclododecane (2).10
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A solution of di-tert-butyl dicarbonate (23.0 g, 106 mmol) in chloroform (130 mL) was added
dropwise over the course of 2 h to a solution of cyclen (6.0 g, 35 mmol) and triethylamine (15
mL, 106 mmol) in chloroform (170 mL) at 0 °C. The resulting solution allowed to warm to
room temperature and stirred for 18 h. The reaction mixture was then washed with water (2 ×
100 mL), the organic layer was dried over Na2SO4, and the solvents were removed in vacuo.
The residue was purified by column chromatography over a silica gel eluting with diethyl ether
to afford the title compound as a colorless solid (14.8 g, 90%). Rf = 0.3 (SiO2, Et2O). Mp =
72–73.5 °C. 1H NMR (270 MHz, CDCl3): δ = 3.50 (4H, s br, ring CH2), 3.15 (8H, s br, ring
CH2), 2.71 (4H, s br, ring CH2), 1.33 (9H, s, C(CH3)3), 1.31 (18H, s, C(CH3)3). 13C NMR
(67.5 MHz, CDCl3): δ = 28.5 (C(CH3)3), 28.7 (C(CH3)3), 45.9 (ring CH2), 48.9 (ring CH2),
49.5 (ring CH2), 51.0 (ring CH2), 79.1 (C(CH3)3), 79.3 (C(CH3)3), 155.4 (C═O), 155.6 (C═O).
νmax/cm−1: 3312 (NH), 2976, 2932, 2815, 1690 (C═O), 1463, 1417, 1365, 1248, 1172, 1088,
774. m/z (ESI+); 473 (100% [M + H]+), 495 (5% [M + Na]+). Anal. Found C = 58.3%, H =
9.7%, N = 11.7%. C23H44N4O6 requires C = 58.5%, H = 9.3%, N = 11.9%.
1-Benzyloxycarbonyl-4,7,10-tris-tert-butoxycarbonyl-1,4,7,10-tetraazacyclododecane (3)
To a cooled solution (0 °C) of the tri-Boc-protected cyclen 2 (6.6 g, 14.0 mmol) and
triethylamine (2.4 mL, 16.7 mmol) in chloroform (150 mL) was added benzyl chloroformate
(2.9 g, 16.7 mmol). The resulting solution was allowed to warm to room temperature and stirred
for 8 h. The precipitates were removed by filtration, and the solvents were removed in vacuo.
The residue was purified by column chromatography over silica gel eluting with 30% ethyl
acetate in hexanes to afford the title compound as a colorless solid (8.3 g, 98%). Rf = 0.5
(SiO2, 30% EtOAc hexanes). Mp = 76.5–77.5 °C. 1H NMR (270 MHz, CDCl3): δ = 7.28 (5H,
m, Ph), 5.04 (2H, s, OCH2Ph), 3.44 (6H, s br, NCH2CO), 3.32 (16H, m br, ring CH2), 1.38
(9H, s, C(CH3)3), 1.35 (18H, s, C(CH3)3). 13C NMR (67.5 MHz, CDCl3): δ = 28.4 (C
(CH3)3), 28.5 (C(CH3)3), 50.3 (br, ring CH2), 67.2 (OCH2Ph), 79.9 (C(CH3)3), 128.1 (4-Ph),
128.3 (3-Ph) 128.5 (2-Ph), 136.5 (1-Ph), 156.6 (br, C═O). νmax/cm−1: 3064, 3029, 3004, 2976,
2933, 1694 (C═O), 1468, 1411, 1366, 1248, 1165, 1102, 1028, 776. A suitable analysis of this
compound could not be obtained.

NIH-PA Author Manuscript

1-Benzyloxycarbonyl-1,4,7,10-tetraazacyclododecane Trihydrochloride (4)
To a cooled solution (0 °C) of the protected cyclen 3 (8.0 g, 13.2 mmol) in methanol (10 mL)
was added concentrated HCl (10 mL) dropwise. The resulting solution was allowed to warm
to room temperature and stirred for 8 h. The reaction was concentrated at room temperature
under reduced pressure to a volume of 15 mL, and the precipitates were removed by filtration.
The residue was then crystallized from a mixture of water and tetrahydrofuran to afford the
title compound as a colorless crystalline solid (5.1 g, 94%). Mp = 191.5–192.5 °C. 1H NMR
(270 MHz, CD3OD): δ = 7.40 (5H, m, Ph), 5.15 (2H, s, OCH2Ph), 3.14 (16H, m, ring
CH2). 13C NMR (67.5 MHz, CD3-OD): δ = 43.0 (ring CH2), 44.7 (ring CH2), 45.4 (ring
CH2), 46.7 (ring CH2), 68.8 (OCH2Ph), 128.5 (3-Ph), 128.9 (4-Ph), 129.0 (2-Ph), 135.8 (1Ph), 158.5 (C═O). νmax/cm−1: 3430 (NH), 2997, 2806, 1709 (C═O), 1622, 1447, 1261, 1162,
767, 741. m/z (ESI+); 307 (100% [M + H]+), 329 (3% [M + Na]+). Anal. Found C = 45.9%,
H = 7.5%, N = 12.8%. C16H29N4O2•3HCl•0.4H2O requires C = 45.4%, H = 7.1%, N = 13.2%.
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1-Benzyloxycarbonyl-4,7,10-tris(carbamoylmethyl)-1,4,7,10-tetraazacyclododecane (5)
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The trihydrochloride salt 4 (4.1 g, 9.8 mmol) was dissolved in aqueous sodium hydroxide
solution (20 mL, 1 N) and extracted with chloroform (3 × 20 mL). The organic extracts were
dried (Na2SO4), and the solvents were removed in vacuo. The resultant solid was dissolved in
acetonitrile (60 mL), and anhydrous potassium carbonate (5.2 g, 39.0 mmol) was added. The
solution was then heated to 60 °C for 20 min before bromoacetamide (5.4 g, 39.4 mmol) was
added, and the reaction mixture stirred at 70 °C for a further 18 h. The solvents were removed
in vacuo, and the residue was dissolved in water (10 mL) and extracted with dichloromethane
(3 × 50 mL). The product was purified by flash column chromatography over silica gel eluting
with chloroform/methanol (5:2) to yield the title compound as a colorless solid (4.21 g, 90%).
Rf = 0.45 (SiO2, CHCl3/MeOH, 5:2). Mp = 154–154.5 °C. 1H NMR (270 MHz, CDCl3): δ =
7.30 (5H, m, Ph), 7.01 (1H, s br, NH), 6.93 (2H, s br, NH), 6.81 (1H, s br, NH), 6.70 (2H, s
br, NH), 5.06 (2H, s, OCH2Ph), 3.44 (6H, s br, NCH2CO), 3.25-2.55 (16H, m, ring
CH2). 13C NMR (67.5 MHz, CDCl3): δ = 53.3 (ring CH2), 53.6 (ring CH2), 54.2 (ring CH2),
58.3 (br, NCH2CO), 67.5 (OCH2Ph), 128.3 (3-Ph and 4-Ph), 128.7 (2-Ph), 136.5 (1-Ph), 156.9
(NCO2), 174.6 (C═O), 174.7 (C═O). νmax/cm−1: 3414 (NH), 2937, 2822, 1670 (C═O), 1473,
1456, 1261, 1164, 1118, 995, 755, 604. m/z (ESI+); 478 (100% [M + H]+).
1,4,7,10-Tetraazacyclododecane-1,4,7-triacetamide (DO3AM)
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Benzyloxycarbonyl-protected DO3AM 5 (2.2 g, 4.6 mmol) was dissolved in ethanol (50 mL),
and 10% palladium on carbon (0.5 g) was added. The reaction mixture was then shaken on a
Parr hydrogenator under a hydrogen pressure of 45 psi at room temperature for 12 h. The
reaction was filtered, and the solvents were removed in vacuo to afford the title compound as
a colorless solid (1.63 g, 99%). Mp = 232–234 °C. 1H NMR (270 MHz, CD3OD): δ 3.19 (4H,
s, CH2CO), 3.13 (2H, s, CH2CO), 2.73-2.57 (16H, m br, ring CH2), 13C NMR (67.5 MHz,
CD3-OD): δ 44.9 (ring CH2), 51.2 (ring CH2), 51.4 (ring CH2), 52.4 (ring CH2), 56.4
(CH2CO), 57.9 (CH2CO), 175.2 (C═O), 175.4 (C═O). νmax/cm−1: 3390 (NH), 3177 (NH),
2967, 2832, 1668 (C═O), 1611, 1454, 1330, 1286, 1107, 1001, 925, 776, 609. m/z (ESI+): 344
(100% [M + H]+), 366 (63% [M + Na]+). Anal. Found C = 43.4%, H = 8.8%, N = 25.0%
C14H29N7O3•2.5H2O requires C = 43.3%, H = 8.8%, N = 25.2%.
1-Methlyene-(p-nitrophenol)-1,4,7,10-tetraazacyclododecane-4,7,10-triacetamide (NPDO3AM)

NIH-PA Author Manuscript

To a solution of DO3AM (0.13 g, 0.38 mmol) in ethanol (100 mL) was added 2-hydroxy-5nitrobenzyl bromide (0.09 g, 0.38 mmol) and the mixture heated to 60 °C. After 1 h potassium
carbonate (0.05 g, 0.38 mmol) was added and the reaction stirred at 60 °C for a further 12 h.
After cooling to room temperature the reaction mixture was filtered, and the solvents were
removed in vacuo. The residue was then crystallized for a mixture of methanol and acetonitrile
to afford the ligand as a pale-yellow solid (1.2 g, 65%). Mp = 103–105 °C. 1H NMR (270 MHz,
D2O): δ = 8.09 (1H, s, 3-Ph), 7.99 (1H, d, 3JH-H = 9 Hz, 5-Ph), 6.47 (1H, d, 3JH-H = 9 Hz, 6Ph), 4.43 (2H, s, CH2Ar), 3.20 (4H, s, CH2CO), 3.12 (2H, s, CH2-CO), 2.52–2.82 (16H, m br,
ring CH2N). 13C NMR (67.5 MHz, CDCl3): δ = 44.7 (ring CH2N), 49.5 (ring CH2N), 51.2
(ring CH2N), 53.4 (ring CH2N), 56.1 (CH2CO), 66.4 (CH2CO), 67.7 (CH2Ar), 118.7 (2-Ph),
126.6 (5-Ph), 127.0 (3-Ph), 127.3 (6-Ph), 134.7 (4-Ph), 173.2 (1-Ph), 176.3 (C═O), 176.6
(C═O). m/z (ESI+): 495 (100% [M + H]+). Anal. Found C = 46.0%, H = 7.4%, N = 20.8%
C21H34N8O6•3H2O requires C = 46.0%, H = 7.4%, N = 20.4%.
Preparation of the Lanthanide(III) Complexes of NP-DO3A
An aqueous lanthanide chloride solution (0.4 mmol in 1.5 mL) was added in 200-µL aliquots
to a solution of NP-DO3A (0.2 g, 0.4 mmol) in water (5 mL, pH 2). The pH of the solution
was maintained between 4 and 5 throughout the addition process via the addition of 1 N KOH.
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Complexation progress was monitored by reverse phase HPLC (PRP-1 10 µm/250 mm × 4.1
mm, 30% MeOH, λmax = 254 nm, flow rate of 1 mL/min; ligand tR = 2.6 min, chelate tR = 10.9
min). HRMS (MALDI): C21H29N5O9Eu ([EuLH]+) requires 648.1278, found 648.1288;
C21H29N5O9Gd ([GdLH]+) requires 653.1260, found 653.1227; C21H29N5O9Tb ([TbLH]+)
requires 654.1221, found 654.1212; C21H29N5O9Dy ([DyLH]+) requires 659.1257, found
659.1234.
Preparation of the Lanthanide(III) Complexes of NP-DO3AM
To a solution of NP-DO3AM (50 mg, 0.1 mmol) in water (4 mL) was added a solution of the
appropriate lanthanide chloride or triflate (0.1 mmol) in aqueous solution (4 mL). The reaction
was heated at 60 C for 18 h. After cooling to room temperature the complex was dried by
lyophilization. The complexes were employed without further purification. m/z (ESI+); Eu(NPDO3AM), 643 (100% [151EuL]+), 645 (100% [153EuL]+); Gd(NP-DO3AM), 650 (100%
[GdL]+); an appropriate isotope pattern was observed; Tb(NP-DO3AM), 651 (100% [TbL]+);
Dy(NP-DO3AM), 654 (100% [DyL]+); an appropriate isotope pattern was observed.
Crystal Structure Determination of Eu(NP-DO3AM)(H2O)-(CF3SO3)2
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The structure is presented in Figure 1. Crystals were grown from aqueous solution at pH 5 by
slow evaporation at room temperature: C23H35EuF6N8O13S2, mass = 961.67, triclinic, P1̄, a
= 11.042 (2) Å, b = 11.956 (2) Å, c = 13.723 (3) Å, α = 92.36 (3)°, β = 105.63 (3)°, γ = 101.76
(3) °, U = 1699.2 (6) Å3, Z = 2, Dχ = 1.880 gcm−3, λ(Mo Kα) = 0.71073 Å, μ = 2.076 mm−1,
F(000) = 964, T = 293 K. The sample was studied on a Bruker CCD 1000. The data collection
gave 4844 unique reflections. Refinement was performed using a full-matrix least-squares
method on F2 using SHELXTL, version 5. This procedure afforded a final R (I > 2σ(I)) of R1
= 0.0422; wR2 = 0.1741. For all data R1 = 0.0828; wR2 = 0.2168.
Kinetic Stability Profiles of 177Lu(NP-DO3A)
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A stock 177Lu solution was prepared by adding 2 µL of a 0.3 mM solution of 177LuCl3 in 0.1
N HCl to 2 mL of a 0.3 mM solution of LuCl3 also in 0.1 N HCl. A similar stock solution of
the ligand was prepared in deionized water. The complex was prepared at a 5:1 ligand/metal
ratio by combining appropriate aliquots of each standard solution at pH 2. The pH was then
adjusted to pH 7 using 0.1 N NaOH. The extent of complex formation was determined by
passing a sample of the complex solution through a Sephadex G-50 column eluting with 4:1
saline (0.85% NaCl/NH4OH). Two 3-mL fractions were collected, and the amount of
radioactivity in the combined elutions was compared to that remaining on the resin. Only free
metal was retained on the resin. Once the complexation reaction had reached >98% completion,
a pH stability profile was then generated. Aliquots were taken from the complexation reaction
at pH 7, and the pH adjusted to high and low pH points. The solutions were then allowed to
equilibrate, and aliquots were removed at intervals (5 min, 2 h, 6 h, and 24 h). The amount of
free lutetium versus the amount of complex present in each individual sample pH point was
then measured by using the radioactivity counting method described above. To assess the effect
of Zn2+ the 177Lu complex was prepared with a 3:1 ligand/metal ratio, the pH was adjusted to
7.4, and 3 equiv of ZnCl2 were added. Aliquots were removed from the reaction at (5 min, 2
h, 16 h,and 24 h), and the extent of transmetalation was measured using the same radioactivity
counting method.
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Figure 1.

Crystal structure of Eu(NP-DO3AM)(H2O)(CF3SO2−)2 showing a side view (upper) and top
view (lower). Hydrogen atoms bonded to carbon have been omitted for clarity. The structure
shown is the Δ(λλλλ) conformer, the Λ(δδδδ) conformer, cocrystallized in the P1̄ unit cell, is
not shown. The dotted lines indicate the hydrogen-bonding interactions of the coordinated
water molecule and the triflate anions. An ORTEP rendering of the structure is included in the
ESI.
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Figure 2.

Relaxivity pH profiles of Gd(NP-DO3A) (filled diamonds) and Gd(NP-DO3AM) (open
squares) recorded at 25 °C and 20 MHz.
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Figure 3.

Effect of pH on the terbium emission lifetime of Tb(NP-DO3A) at (λex = 270 nm, λem = 545
nm) (open circles), shown with the relaxivity profile of Gd(NP-DO3A) (filled diamonds).
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Figure 4.

Jablonski diagrams of the terbium complexes of NP-DO3A (left) and NP-DO3AM (right)
showing that the proximity of the triplet energy level of the nitrophenol group causes substantial
back energy transfer in these complexes.
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Figure 5.

Relaxivity pH profile of Gd(NP-DO3AM) plotted alongside the data from the potentiometric
titration of Yb(NP-DO3AM). The pKa of the complex at 7.22 corresponds to the onset of the
relaxivity enhancement as the pH is lowered.

NIH-PA Author Manuscript
J Am Chem Soc. Author manuscript; available in PMC 2009 September 10.

Woods et al.

Page 18

NIH-PA Author Manuscript
NIH-PA Author Manuscript
Figure 6.

Complex Lu(NP-DO3A) is stable over the pH range 4–11 for up to 24 h, with greater than 98%
of the complex remaining intact in this pH range. Dissociation of the complex is only observed
at pH 3 or below.
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Synthesis of NP-DO3Aa
a Reagents and conditions: i. 2-hydroxyl-5-nitrobenzyl bromide/dioxane (55%) ii.
BrCH2CO2H/H2O/pH 8.5 (49%).
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Scheme 2.

Synthesis of NP-DO3AMa
a Reagents and conditions: i. (Boc) O/CHCl (90%), ii. BnOCOCl/Et N/CHCl (98%), iii.
2
3
3
3
HCl/MeOH (94%), iv. BrCH2CONH2/MeCN/K2CO3 (90%), v. H2/10% Pd on C/EtOH (99%),
vi. 2-hydroxyl-5-nitrobenzyl bromide/K2CO3/EtOH (65%).
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Chart 1.

Structures of 1-Methlyene-(p-NitroPhenol)-1,4,7,10-tetraazacycloDOdecane-4,7,10triAcetate (NP-DO3A) and 1-Methlyene- (p-NitroPhenol)-1,4,7,10tetraazacycloDOdecane-4,7,10-triacetAMide (NP-DO3AM)
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Table 1

Crystal Structure Determination of Eu(NP-DO3AM)(H2O)(CF3SO2−)2

NIH-PA Author Manuscript

formula

C23H35EuF6N8O13S2

formula mass

961.67

temperature

293 K

crystal system

triclcinic

space group

P1̄

unit cell
a (Å)

11.042(2)

b (Å)

11.956(2)

c (Å)

13.723(3)

α (deg)

92.36

β (deg)

105.63

γ (deg)

101.76(3)
3

NIH-PA Author Manuscript

volume (Å )

1699.2(6)

Z

2

final R (I > 2σ(I))

R1 = 0.0422; wR2 = 0.1741

R (all data)

R1 = 0.0828; wR2 = 0.2168

GOF

1.01
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Table 2

Selected Angles (deg) and Bond Distances (Å) from the Crystal Structure of Eu
(NP-DO3AM)(H2O)(CF3SO2−)2

NIH-PA Author Manuscript

Angles
N1–C2–C3–N4

56.7

N4–C5–C6–N7

60.4

N7–C8–C9–N10

61.0

N10–C11–C12–N1

64.4

N4–C41–C42–O41

13.7

N7–C71–C72–O71

3.3

N10–C101–C102–O101

26.7

N(1)–Eu(1)–O(15)

74.4 (2)

N(4)–Eu(1)–O(41)

65.4 (2)

N(7)–Eu(1)–O(71)

63.9 (2)

N(10)–Eu(1)–O(101)

64.8 (2)

O(15)–Eu(1)–O(1W)

68.2 (2)

O(41)–Eu(1)–O(1W)

75.0 (2)

O(71)–Eu(1)–O(1W)

68.0 (2)

NIH-PA Author Manuscript

O(101)–Eu(1)–O(1W)

70.9 (2)
Bond Lengths

Eu(1)–O(1W)

2.486 (5)

Eu(1)–O(15)

2.242 (5)

Eu(1)–O(41)

2.382 (5)

Eu(1)–O(71)

2.403 (5)

Eu(1)–O(101)

2.387 (5)

Eu(1)–N(1)

2.643 (6)

Eu(1)–N(4)

2.685 (6)

Eu(1)–N(7)

2.745 (6)

Eu(1)–N(10)

2.676 (6)

a

The full data set has been deposited with the Cambridge Crystallographic Database.
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